Jupiter Neurosciences Cash Flow Statement (2024-2025) | JUNS

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.64M-0.61M-0.60M-1.48M-1.53M-2.25M-2.29M-2.87M
Share-based Compensation (Quarter) 0.10M0.53M-0.63M0.89M0.42M0.35M0.39M0.39M
Gains from Investment Securities (Quarter) 0.30M0.30M10.63M0.25M1.09M1.09M
Non-cash Items (Quarter) 3.32M102.92M10.34M1.77M10.81M1.77M
Cash from Operations (Quarter) -0.07M-0.11M-0.04M-3.70M-1.06M-0.83M-1.15M-2.37M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.00M0.00M0.01M0.03M
Change in Working Capital
Change in Accured Expenses (Quarter) 0.01M0.02M0.08M-0.27M-0.11M0.56M-0.01M-0.40M
Other Working Capital Changes (Quarter) 0.14M0.02M0.04M-0.03M-0.04M
Financing Activities
Cash from Financing Activities (Quarter) 0.04M0.11M0.03M7.47M
Additional items
Change in Cash (Quarter) -0.02M0.01M-0.01M3.77M-1.06M-0.83M-1.15M3.07M
Free Cash Flow (Quarter) -0.07M-0.11M-0.04M-3.70M-1.06M-0.83M-1.15M-2.37M
Net Cash Flow (Quarter) -0.02M0.01M-0.01M3.77M-1.06M-0.83M-1.15M-2.37M